371 related articles for article (PubMed ID: 31395880)
1. Proteogenomic landscape of squamous cell lung cancer.
Stewart PA; Welsh EA; Slebos RJC; Fang B; Izumi V; Chambers M; Zhang G; Cen L; Pettersson F; Zhang Y; Chen Z; Cheng CH; Thapa R; Thompson Z; Fellows KM; Francis JM; Saller JJ; Mesa T; Zhang C; Yoder S; DeNicola GM; Beg AA; Boyle TA; Teer JK; Ann Chen Y; Koomen JM; Eschrich SA; Haura EB
Nat Commun; 2019 Aug; 10(1):3578. PubMed ID: 31395880
[TBL] [Abstract][Full Text] [Related]
2. A proteogenomic portrait of lung squamous cell carcinoma.
Satpathy S; Krug K; Jean Beltran PM; Savage SR; Petralia F; Kumar-Sinha C; Dou Y; Reva B; Kane MH; Avanessian SC; Vasaikar SV; Krek A; Lei JT; Jaehnig EJ; Omelchenko T; Geffen Y; Bergstrom EJ; Stathias V; Christianson KE; Heiman DI; Cieslik MP; Cao S; Song X; Ji J; Liu W; Li K; Wen B; Li Y; Gümüş ZH; Selvan ME; Soundararajan R; Visal TH; Raso MG; Parra ER; Babur Ö; Vats P; Anand S; Schraink T; Cornwell M; Rodrigues FM; Zhu H; Mo CK; Zhang Y; da Veiga Leprevost F; Huang C; Chinnaiyan AM; Wyczalkowski MA; Omenn GS; Newton CJ; Schurer S; Ruggles KV; Fenyö D; Jewell SD; Thiagarajan M; Mesri M; Rodriguez H; Mani SA; Udeshi ND; Getz G; Suh J; Li QK; Hostetter G; Paik PK; Dhanasekaran SM; Govindan R; Ding L; Robles AI; Clauser KR; Nesvizhskii AI; Wang P; Carr SA; Zhang B; Mani DR; Gillette MA;
Cell; 2021 Aug; 184(16):4348-4371.e40. PubMed ID: 34358469
[TBL] [Abstract][Full Text] [Related]
3. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.
Gillette MA; Satpathy S; Cao S; Dhanasekaran SM; Vasaikar SV; Krug K; Petralia F; Li Y; Liang WW; Reva B; Krek A; Ji J; Song X; Liu W; Hong R; Yao L; Blumenberg L; Savage SR; Wendl MC; Wen B; Li K; Tang LC; MacMullan MA; Avanessian SC; Kane MH; Newton CJ; Cornwell M; Kothadia RB; Ma W; Yoo S; Mannan R; Vats P; Kumar-Sinha C; Kawaler EA; Omelchenko T; Colaprico A; Geffen Y; Maruvka YE; da Veiga Leprevost F; Wiznerowicz M; Gümüş ZH; Veluswamy RR; Hostetter G; Heiman DI; Wyczalkowski MA; Hiltke T; Mesri M; Kinsinger CR; Boja ES; Omenn GS; Chinnaiyan AM; Rodriguez H; Li QK; Jewell SD; Thiagarajan M; Getz G; Zhang B; Fenyö D; Ruggles KV; Cieslik MP; Robles AI; Clauser KR; Govindan R; Wang P; Nesvizhskii AI; Ding L; Mani DR; Carr SA;
Cell; 2020 Jul; 182(1):200-225.e35. PubMed ID: 32649874
[TBL] [Abstract][Full Text] [Related]
4. Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways.
Soltis AR; Bateman NW; Liu J; Nguyen T; Franks TJ; Zhang X; Dalgard CL; Viollet C; Somiari S; Yan C; Zeman K; Skinner WJ; Lee JSH; Pollard HB; Turner C; Petricoin EF; Meerzaman D; Conrads TP; Hu H; ; Shriver CD; Moskaluk CA; Browning RF; Wilkerson MD
Cell Rep Med; 2022 Nov; 3(11):100819. PubMed ID: 36384096
[TBL] [Abstract][Full Text] [Related]
5. A subtype of oral, laryngeal, esophageal, and lung, squamous cell carcinoma with high levels of TrkB-T1 neurotrophin receptor mRNA.
Zhou Y; Sinha S; Schwartz JL; Adami GR
BMC Cancer; 2019 Jun; 19(1):607. PubMed ID: 31221127
[TBL] [Abstract][Full Text] [Related]
6. Multi-omics analysis at epigenomics and transcriptomics levels reveals prognostic subtypes of lung squamous cell carcinoma.
Xu Y; She Y; Li Y; Li H; Jia Z; Jiang G; Liang L; Duan L
Biomed Pharmacother; 2020 May; 125():109859. PubMed ID: 32036209
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological, microenvironmental and genetic determinants of molecular subtypes in KEAP1/NRF2-mutant lung cancer.
Cai MC; Chen M; Ma P; Wu J; Lu H; Zhang S; Liu J; Zhao X; Zhuang G; Yu Z; Fu Y
Int J Cancer; 2019 Feb; 144(4):788-801. PubMed ID: 30411339
[TBL] [Abstract][Full Text] [Related]
8. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
Faruki H; Mayhew GM; Serody JS; Hayes DN; Perou CM; Lai-Goldman M
J Thorac Oncol; 2017 Jun; 12(6):943-953. PubMed ID: 28341226
[TBL] [Abstract][Full Text] [Related]
9. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
Staaf J; Isaksson S; Karlsson A; Jönsson M; Johansson L; Jönsson P; Botling J; Micke P; Baldetorp B; Planck M
Int J Cancer; 2013 May; 132(9):2020-31. PubMed ID: 23023297
[TBL] [Abstract][Full Text] [Related]
10. Genomic Copy Number Signatures Uncovered a Genetically Distinct Group from Adenocarcinoma and Squamous Cell Carcinoma in Non-Small Cell Lung Cancer.
Lee E; Moon JW; Wang X; Kim C; Li S; Shin BK; Jung W; Kim HK; Kim HK; Lee JY
Hum Pathol; 2015 Aug; 46(8):1111-20. PubMed ID: 26003479
[TBL] [Abstract][Full Text] [Related]
11. Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways.
Zhang Y; Chen F; Chandrashekar DS; Varambally S; Creighton CJ
Nat Commun; 2022 May; 13(1):2669. PubMed ID: 35562349
[TBL] [Abstract][Full Text] [Related]
12. Current status of clinical proteogenomics in lung cancer.
Nishimura T; Nakamura H; Végvári Á; Marko-Varga G; Furuya N; Saji H
Expert Rev Proteomics; 2019 Sep; 16(9):761-772. PubMed ID: 31402712
[No Abstract] [Full Text] [Related]
13. Integrated analyses of copy number variations and gene differential expression in lung squamous-cell carcinoma.
Yang Z; Zhuan B; Yan Y; Jiang S; Wang T
Biol Res; 2015 Aug; 48(1):47. PubMed ID: 26297502
[TBL] [Abstract][Full Text] [Related]
14. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
[TBL] [Abstract][Full Text] [Related]
15. Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis.
Boelens MC; Kok K; van der Vlies P; van der Vries G; Sietsma H; Timens W; Postma DS; Groen HJ; van den Berg A
Lung Cancer; 2009 Dec; 66(3):372-8. PubMed ID: 19324446
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA induction by copy number gain is associated with poor outcome in squamous cell carcinoma of the lung.
Xia E; Kanematsu S; Suenaga Y; Elzawahry A; Kondo H; Otsuka N; Moriya Y; Iizasa T; Kato M; Yoshino I; Yokoi S
Sci Rep; 2018 Oct; 8(1):15363. PubMed ID: 30337605
[TBL] [Abstract][Full Text] [Related]
17. Somatic alterations of the serine/threonine kinase LKB1 gene in squamous cell (SCC) and large cell (LCC) lung carcinoma.
Strazisar M; Mlakar V; Rott T; Glavac D
Cancer Invest; 2009 May; 27(4):407-16. PubMed ID: 19229701
[TBL] [Abstract][Full Text] [Related]
18. Copy number changes of target genes in chromosome 3q25.3-qter of esophageal squamous cell carcinoma: TP63 is amplified in early carcinogenesis but down-regulated as disease progressed.
Yen CC; Chen YJ; Pan CC; Lu KH; Chen PC; Hsia JY; Chen JT; Wu YC; Hsu WH; Wang LS; Huang MH; Huang BS; Hu CP; Chen PM; Lin CH
World J Gastroenterol; 2005 Mar; 11(9):1267-72. PubMed ID: 15761962
[TBL] [Abstract][Full Text] [Related]
19. Lymph node metastasis in lung squamous cell carcinoma and identification of metastasis-related genes based on the Cancer Genome Atlas.
Dong M; Gong H; Li T; Li X; Liu J; Zhang H; Liu M; Chen G; Liu H; Chen J
Cancer Med; 2019 Oct; 8(14):6280-6294. PubMed ID: 31482686
[TBL] [Abstract][Full Text] [Related]
20. Analysis of gene expression profiles of lung cancer subtypes with machine learning algorithms.
Yuan F; Lu L; Zou Q
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165822. PubMed ID: 32360590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
